Stay updated on Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.

Latest updates to the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe history shows the study is no longer recruiting participants, and the record version has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

- Check19 days agoChange DetectedA new version entry (Version 21) was added on 2026-05-29, including an updated Study Status and the revision label Revision: v3.5.5, reflecting a newer revision of the study record.SummaryDifference0.4%

- Check41 days agoChange DetectedNew Study Status entry dated 2026-05-12 was added and the record revision updated to v3.5.4, while the 2026-04-01 entry and Revision v3.5.3 were removed, reflecting an updated history of the study record.SummaryDifference0.4%

- Check55 days agoChange DetectedThe page’s revision tag was updated from v3.5.2 to v3.5.3. This represents a minor site update rather than changes to the study data or page content.SummaryDifference0.1%

- Check69 days agoChange DetectedA new site revision entry (Revision: v3.5.2) was added and an older revision (Revision: v3.5.0) was removed.SummaryDifference0.2%

- Check84 days agoChange DetectedNew entries were added to the Record History for 2026-03-19 and 2026-04-01 (Study Status). An entry was removed on 2026-03-12.SummaryDifference0.3%

Stay in the know with updates to Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.